ROYAL BANK OF CANADA - APYX MEDICAL CORPORATION ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of APYX MEDICAL CORPORATION
ValueSharesWeighting
Q3 2023$64,000
+392.3%
19,954
+942.0%
0.00%
Q1 2022$13,000
-88.8%
1,915
-78.8%
0.00%
Q4 2021$116,000
+52.6%
9,018
+65.2%
0.00%
Q3 2021$76,000
+245.5%
5,459
+155.6%
0.00%
Q2 2021$22,000
-8.3%
2,136
-14.4%
0.00%
Q1 2021$24,000
+166.7%
2,495
+107.2%
0.00%
Q4 2020$9,0001,204
+2215.4%
0.00%
Q3 2020$0
-100.0%
52
-75.7%
0.00%
Q2 2020$1,0000.0%214
+13.8%
0.00%
Q1 2020$1,000
-95.2%
188
-92.5%
0.00%
Q4 2019$21,000
+2000.0%
2,515
+1138.9%
0.00%
Q3 2019$1,0002030.00%
Other shareholders
APYX MEDICAL CORPORATION shareholders Q4 2023
NameSharesValueWeighting ↓
Archon Capital Management LLC 2,449,402$23,661,0003.40%
Taylor Frigon Capital Management LLC 611,712$5,909,0001.82%
Roubaix Capital, LLC 180,874$1,747,0001.18%
Millrace Asset Group, Inc. 176,587$1,706,0000.92%
Cowen Prime Services LLC 248,959$2,405,0000.91%
RTW INVESTMENTS, LP 3,391,279$32,760,0000.51%
Lighthouse Financial Advisors, Inc. 162,598$1,570,0000.48%
COWEN AND COMPANY, LLC 522,042$5,043,0000.35%
WOLFF WIESE MAGANA LLC 37,017$358,0000.28%
PURA VIDA INVESTMENTS, LLC 958,488$9,259,0000.26%
View complete list of APYX MEDICAL CORPORATION shareholders